Ryeqo 40 mg/1 mg/0.5 mg Tablets: Uses, Safety & Doc History
Quick summary: Ryeqo 40 mg/1 mg/0.5 mg film-coated tablets is a prescription hormonal medicine containing relugolix, estradiol and norethisterone acetate. It is used for moderate to severe symptoms linked to uterine fibroids and endometriosis...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Ryeqo 40 mg/1 mg/0.5 mg film-coated tablets is a prescription hormonal medicine containing relugolix, estradiol and norethisterone acetate. It is used for moderate to severe symptoms linked to uterine fibroids and endometriosis in adult women. Always follow the official leaflet and your prescriber’s instructions.
Medical disclaimer: This article is for general information only and does not replace advice from a doctor, pharmacist, or the official product information. Do not use this page to self-diagnose, and do not change any prescribed treatment without professional guidance.
What Ryeqo is
Ryeqo 40 mg/1 mg/0.5 mg film-coated tablets is a combination medicine with three active ingredients: relugolix, estradiol, and norethisterone acetate. It is described as a treatment for symptoms associated with uterine fibroids and endometriosis.
The content provided for this page indicates that Ryeqo is intended to help manage heavy menstrual bleeding and pain related to these conditions.
Summary of product characteristics
According to the source content, Ryeqo is a prescription medicine used in adult women and is taken once daily. It was approved for use in Switzerland on 2 February 2024.
Because this is a hormonal combination medicine, it is important to review the official product information for the most up-to-date details on use, warnings, and monitoring.
What Ryeqo is used for
Ryeqo is used for the management of moderate to severe symptoms of uterine fibroids and endometriosis. These conditions can affect quality of life through symptoms such as bleeding and pain.
The original content notes that Ryeqo may be especially relevant when other treatments have not provided enough relief. Any treatment choice should be made with a healthcare professional who can assess the full clinical picture.
How Ryeqo is taken
Ryeqo should be taken exactly as prescribed. The source content states that the usual approach is one tablet daily, with or without food.
- Take it at the same time each day if possible.
- Swallow the tablet whole; do not crush or chew it.
- If you miss a dose, follow the advice from your doctor, pharmacist, or the patient leaflet.
Before starting treatment, it is important to discuss your medical history with a healthcare professional, including any possibility of pregnancy and any other medicines you use.
Storage information
Store Ryeqo in its original packaging and protect it from moisture and heat. The source content states a storage temperature of 15°C to 25°C.
Keep the tablets out of reach of children and check the expiry date regularly. Dispose of expired medicine safely according to local guidance.
Prescription status
Ryeqo is a prescription medicine. The original content states that a healthcare provider should assess whether it is appropriate for the individual patient and monitor treatment as needed.
If you are unsure whether the medicine on your prescription matches the product you have, confirm the name, strength, and instructions with a pharmacist before use.
Pregnancy and Ryeqo
The source content says Ryeqo is not recommended during pregnancy. If pregnancy is possible or planned, this should be discussed with a healthcare professional before treatment begins.
Because this medicine contains hormonal components, the official leaflet and prescriber guidance are important sources for pregnancy-related precautions.
Possible side effects
Like all medicines, Ryeqo can cause side effects. The original content lists the following examples:
- Nausea
- Headache
- Fatigue
- Bone density loss
If side effects are severe, persistent, or worrying, speak to a healthcare professional. Regular follow-up may be needed to review benefit and tolerability.
Key points to verify with the leaflet or pharmacist
If you have been prescribed Ryeqo, it is sensible to confirm the following details from the official leaflet or your pharmacist:
- How to take the tablet if a dose is missed
- What to do if vomiting occurs after a dose
- Which other medicines may need review
- Any monitoring your prescriber wants during treatment
- How long treatment is intended to continue
Frequently asked questions
▸ When was Ryeqo approved in Switzerland?
The source content states that Ryeqo was approved for use in Switzerland on 2 February 2024.
▸ What active ingredients does Ryeqo contain?
Ryeqo contains relugolix, estradiol, and norethisterone acetate.
▸ What conditions is Ryeqo used for?
The source content says it is used for moderate to severe symptoms of uterine fibroids and endometriosis.
▸ Is Ryeqo taken once daily?
Yes. The content provided states that Ryeqo is typically taken once daily, as prescribed.
▸ Is Ryeqo safe during pregnancy?
The source content says Ryeqo is not recommended during pregnancy. If pregnancy is possible or planned, speak with a healthcare professional before using it.
▸ What side effects are mentioned in the source content?
The listed examples are nausea, headache, fatigue, and bone density loss.
Safety reminder: If you have been prescribed Ryeqo, use the official patient leaflet and your healthcare professional’s advice as the main reference for safe use. Seek urgent medical help for severe symptoms or if you think you may be pregnant while taking a medicine that should not be used in pregnancy.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- Swissmedic product information / public assessment details
- Official patient leaflet for Ryeqo
- European Medicines Agency medicine overview
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.